Study: GPs inflate valuations during fundraising
A University of Oxford analysis of CalPERS’ private equity portfolio has found that GPs inflate valuations of existing portfolio companies while marketing follow-on funds.
A University of Oxford analysis of CalPERS’ private equity portfolio has found that GPs inflate valuations of existing portfolio companies while marketing follow-on funds.
Copyright PEI Media
Not for publication, email or dissemination